Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings (LH)
NYSE:LH
LH Stock Chart & Stats
$261.48
-$1.45(-0.62%)
At close: 4:00 PM EST
$261.48
-$1.45(-0.62%)
Day’s Range― - ―
52-Week Range$209.38 - $293.72
Previous CloseN/A
Volume103.18K
Average Volume (3M)1.02M
Market Cap
$22.05B
Enterprise Value$29.97B
Total Cash (Recent Filing)$598.10M
Total Debt (Recent Filing)$6.53B
Price to Earnings (P/E)26.1
Beta0.38
Next Earnings
Feb 05, 2026EPS Estimate
3.94Last Dividend Ex-Date
Nov 26, 2025Dividend Yield1.1%
Share Statistics
EPS (TTM)4.18
Shares Outstanding82,900,000
10 Day Avg. Volume661,008
30 Day Avg. Volume1,016,763
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)2.39
Price to Sales (P/S)1.48
P/FCF Ratio17.56
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit7.66
Enterprise Value/Ebitda14.90
Forecast
1Y Price Target
$307.00Price Target Upside17.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)16.33
Revenue Forecast (FY)$14.00B
Bulls Say, Bears Say
Bulls Say
Cash Flow StrengthFree cash flow guidance was raised by $25 million, suggesting stronger financial health.
Diagnostics Segment GrowthThe company is executing well and seeing favorable trends in its diagnostics segment and central labs business, which combine for 94% of total revenue.
Financial PerformanceEarnings exceeded expectations by $0.05, indicating stronger performance than anticipated.
Bears Say
Margin ConcernsShares closed down 6% on the heels of a somewhat mixed update where investors focused on a weaker-than-expected early development business and questions on margin expansion/earnings growth in light of potential PAMA headwinds.
Revenue Guidance ReductionFull-year total revenue guidance was reduced by $45 million due to acquisition timing and incremental foreign exchange headwinds.
Labcorp Holdings News
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $209.38 and its highest was $293.72 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $22.05B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s upcoming earnings report date is Feb 05, 2026 which is in 61 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Oct 28, 2025. The company reported $4.18 earnings per share for the quarter, beating the consensus estimate of $4.13 by $0.05.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.1%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 3.94.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 82,900,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $4.18 in its last earnings report, beating expectations of $4.13. Following the earnings report the stock price went down -5.791%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in LH
Labcorp Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$307.00 (17.41% Upside)
$307.00 (17.41% Upside)
Blogger Sentiment
Bullish
LH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 94.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.36%
12-Months-Change
Fundamentals
Return on Equity
10.14%
Trailing 12-Months
Asset Growth
-1.89%
Trailing 12-Months
Company Description
Labcorp Holdings
Labcorp Holdings (LH) is a global leader in laboratory services, specializing in diagnostic testing, drug development, and related services. The company operates in two primary segments: Labcorp Diagnostics, which provides comprehensive laboratory testing services across various medical disciplines, and Labcorp Drug Development, which offers services to pharmaceutical and biotechnology companies to aid in the drug development process. With a strong focus on innovation and technology, Labcorp aims to improve patient health and advance medical science through its extensive range of tests and clinical development services.
LH Company Deck
LH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Labcorp's earnings call highlighted strong revenue growth, strategic acquisitions, and innovation in testing capabilities, driven by Diagnostics and Central Laboratories success. However, challenges such as lower-than-expected Early Development revenue and potential impacts from PAMA legislation were noted.View all LH earnings summariesLH Revenue Breakdown
77.98% Dx
22.47% BLS
LH Stock 12 Month Forecast
Average Price Target
$307.00
▲(17.41% Upside)
Technical Analysis
Ownership Overview
0.30% Insiders
30.94% Mutual Funds
20.31% Other Institutional Investors
23.72% Public Companies and
Individual Investors